News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
CSPC PHARMA Hyped Up ~8% to 6-Mth+ High; ADC Drug Granted 3rd Fast Track Designation by US FDA
Stretching its upswing from the past two days, CSPC PHARMA (01093.HK) opened 3.9% higher today (20th) and once climbed to an over-six-month high of HKD6.44 in early trading. It las...
Reset
Send
The window will close in 5 seconds
CSPC PHARMA Hyped Up ~8% to 6-Mth+ High; ADC Drug Granted 3rd Fast Track Designation by US FDA
Close
Recommend
11
Positive
15
Negative
12
 
SHORT SELL
 
STOCK INFO

Stretching its upswing from the past two days, CSPC PHARMA (01093.HK)  +0.250 (+3.968%)    Short selling $508.02M; Ratio 24.090%   opened 3.9% higher today (20th) and once climbed to an over-six-month high of HKD6.44 in early trading. It last traded at HKD6.4, up 7.74%, on a volume of 131 million shares, involving HKD827 million.

The company announced last night that CPO301, a first-in-class epidermal growth factor receptor (EGFR) antibody drug conjugate (ADC) developed by the group, has been granted the third Fast Track designation by the US Food and Drug Administration (FDA) for the treatment of adult patients with advanced or metastatic non-squamous non-small cell lung cancer (Nsq-NSCLC) without EGFR mutations or other actional genomic alterations (AGA), with prior disease progression on platinum-based chemotherapy and an anti-PD-(L)1 antibody.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-05-20 16:25.)

Related NewsM Stanley Bullish on CN Pharma Sector, Raising TPs for HANSOH PHARMA, Others

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.